These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22027928)

  • 1. Medication phobia: a new cause of drug noncompliance in Parkinson disease.
    Schlesinger I; Rabinowitz D
    Clin Neuropharmacol; 2011; 34(6):220-3. PubMed ID: 22027928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication management in people with Parkinson's disease during surgical admissions.
    Derry CP; Shah KJ; Caie L; Counsell CE
    Postgrad Med J; 2010 Jun; 86(1016):334-7. PubMed ID: 20547599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to antiparkinson medication in a multicenter European study.
    Grosset D; Antonini A; Canesi M; Pezzoli G; Lees A; Shaw K; Cubo E; Martinez-Martin P; Rascol O; Negre-Pages L; Senard A; Schwarz J; Strecker K; Reichmann H; Storch A; Löhle M; Stocchi F; Grosset K
    Mov Disord; 2009 Apr; 24(6):826-32. PubMed ID: 19191340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal medication adherence in Parkinson's disease.
    Grosset KA; Bone I; Grosset DG
    Mov Disord; 2005 Nov; 20(11):1502-7. PubMed ID: 16037924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990.
    Van Gerpen JA; Kumar N; Bower JH; Weigand S; Ahlskog JE
    Arch Neurol; 2006 Feb; 63(2):205-9. PubMed ID: 16476808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiety disorders in Parkinson's disease: prevalence and risk factors.
    Dissanayaka NN; Sellbach A; Matheson S; O'Sullivan JD; Silburn PA; Byrne GJ; Marsh R; Mellick GD
    Mov Disord; 2010 May; 25(7):838-45. PubMed ID: 20461800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.
    Kulkarni AS; Balkrishnan R; Anderson RT; Edin HM; Kirsch J; Stacy MA
    Mov Disord; 2008 Feb; 23(3):359-65. PubMed ID: 18074366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).
    Fleisher JE; Dahodwala NA; Xie SX; Mayo M; Weintraub D; Chodosh J; Shea JA
    J Parkinsons Dis; 2016 Apr; 6(2):383-92. PubMed ID: 27061070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Othello syndrome in patients with Parkinson's disease.
    Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
    Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Adherence in People With Parkinson Disease.
    Shin JY; Habermann B
    J Neurosci Nurs; 2016; 48(4):185-94. PubMed ID: 27224682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balance problems with Parkinson's disease: are they anxiety-dependent?
    Pasman EP; Murnaghan CD; Bloem BR; Carpenter MG
    Neuroscience; 2011 Mar; 177():283-91. PubMed ID: 21219972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
    Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
    Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures.
    Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
    Parkinsonism Relat Disord; 2015 Jan; 21(1):36-41. PubMed ID: 25465748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicine-taking behavior: implications of suboptimal compliance in Parkinson's disease.
    Grosset KA; Reid JL; Grosset DG
    Mov Disord; 2005 Nov; 20(11):1397-404. PubMed ID: 16092116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing objective from subjective assessments of the severity of medication-related safety events among people with Parkinson's disease: a qualitative study.
    Buetow S; Henshaw J; Cha R; O'Sullivan D
    J Clin Pharm Ther; 2012 Aug; 37(4):436-40. PubMed ID: 22129248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden uncontrollable somnolence and medication use in Parkinson disease.
    Avorn J; Schneeweiss S; Sudarsky LR; Benner J; Kiyota Y; Levin R; Glynn RJ
    Arch Neurol; 2005 Aug; 62(8):1242-8. PubMed ID: 16087765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing medications in Parkinson's disease (PD) patients during acute admissions to a District General Hospital.
    Magdalinou KN; Martin A; Kessel B
    Parkinsonism Relat Disord; 2007 Dec; 13(8):539-40. PubMed ID: 17241810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and strategies of medication adherence in Parkinson's disease: A qualitative study.
    Shin JY; Habermann B; Pretzer-Aboff I
    Geriatr Nurs; 2015; 36(3):192-6. PubMed ID: 25728485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task.
    Sacrey LA; Travis SG; Whishaw IQ
    Behav Brain Res; 2011 Mar; 217(2):391-8. PubMed ID: 21073905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
    Davis KL; Edin HM; Allen JK
    Mov Disord; 2010 Mar; 25(4):474-80. PubMed ID: 20131374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.